Prof. Nakamura of Keio Univ. Sees Orphan Drug Development Strategy as Reason for Revised Re-pricing Policy

Speaking at a seminar held by Uto Brain on January 19, Prof. Hiroshi Nakamura of Keio University noted “a growing trend of orphan drugs becoming blockbusters” as companies pursue a development strategy for obtaining approval for their products as orphan...read more